 | ISERSTHYC | Single Donor Human Thyroid Cancer Serum | 1 Each | Sign In for Pricing | |
 | IPLASTHYC | Single Donor Human Thyroid Cancer Plasma | 1 Each | Sign In for Pricing | |
| NCT231 | Paired Cancer and Normal Thyroid Paraffin Tissue (FFPE) Section | 5 Slides/Pack | Sign In for Pricing | |
| S-HuCAT551 | Human Thyroid Cancer (5 slides/pack, single section/slide) | 1 unit | Sign In for Pricing | |
| 9-47041 | Human Cancer PrimaCell™18: Thyroid Carcinoma Cells Growth Supplements with Serum (for 500 mL medium) | Set | Sign In for Pricing | |
| TS-H5110 | Thyroid Cancer Tissue Slides, Human Paraffin Sections | 5 Slides/Pack | Sign In for Pricing | |
 | HTRT501 | TissueScan, Thyroid Cancer cDNA Array | 10 Panels | Sign In for Pricing | |
 | MBS6369252-01 | AKAP13 (A-kinase Anchor Protein 13, AKAP-13, AKAP-Lbc, Breast Cancer Nuclear Receptor-binding Auxiliary Protein, Guanine Nucleotide Exchange Factor Lbc, Human Thyroid-anchoring Protein 31, Lymphoid Blast Crisis Oncogene, LBC Oncogene, Non-oncogenic Rho GT | 0.1 mL | Sign In for Pricing | |
| MBS6369252-02 | AKAP13 (A-kinase Anchor Protein 13, AKAP-13, AKAP-Lbc, Breast Cancer Nuclear Receptor-binding Auxiliary Protein, Guanine Nucleotide Exchange Factor Lbc, Human Thyroid-anchoring Protein 31, Lymphoid Blast Crisis Oncogene, LBC Oncogene, Non-oncogenic Rho GT | 5x 0.1 mL | Sign In for Pricing | |
| MBS6199468-01 | AKAP13 (A-kinase Anchor Protein 13, AKAP-13, AKAP-Lbc, Breast Cancer Nuclear Receptor-binding Auxiliary Protein, Guanine Nucleotide Exchange Factor Lbc, Human Thyroid-anchoring Protein 31, Lymphoid Blast Crisis Oncogene, LBC Oncogene, Non-oncogenic Rho GT | 0.1 mL | Sign In for Pricing | |
| MBS6199468-02 | AKAP13 (A-kinase Anchor Protein 13, AKAP-13, AKAP-Lbc, Breast Cancer Nuclear Receptor-binding Auxiliary Protein, Guanine Nucleotide Exchange Factor Lbc, Human Thyroid-anchoring Protein 31, Lymphoid Blast Crisis Oncogene, LBC Oncogene, Non-oncogenic Rho GT | 5x 0.1 mL | Sign In for Pricing | |
| MBS6470336-01 | COT, Phosphorylated (Thr290) (Cancer Osaka Thyroid Oncogene, c-COT, EST, ESTF, Mitogen-activated Protein Kinase Kinase Kinase 8, MAP3K8, MEKK8, Proto-oncogene c-Cot, Serine/threonine-protein Kinase Cot, Tumor Progression Locus 2, TPL2, TPL-2) (Biotin) | 0.2 mL | Sign In for Pricing | |
| MBS6470336-02 | COT, Phosphorylated (Thr290) (Cancer Osaka Thyroid Oncogene, c-COT, EST, ESTF, Mitogen-activated Protein Kinase Kinase Kinase 8, MAP3K8, MEKK8, Proto-oncogene c-Cot, Serine/threonine-protein Kinase Cot, Tumor Progression Locus 2, TPL2, TPL-2) (Biotin) | 5x 0.2 mL | Sign In for Pricing | |
 | MBS6470339-01 | COT, Phosphorylated (Thr290) (Cancer Osaka Thyroid Oncogene, c-COT, EST, ESTF, Mitogen-activated Protein Kinase Kinase Kinase 8, MAP3K8, MEKK8, Proto-oncogene c-Cot, Serine/threonine-protein Kinase Cot, Tumor Progression Locus 2, TPL2, TPL-2) (MaxLight 40 | 0.1 mL | Sign In for Pricing | |
| MBS6470339-02 | COT, Phosphorylated (Thr290) (Cancer Osaka Thyroid Oncogene, c-COT, EST, ESTF, Mitogen-activated Protein Kinase Kinase Kinase 8, MAP3K8, MEKK8, Proto-oncogene c-Cot, Serine/threonine-protein Kinase Cot, Tumor Progression Locus 2, TPL2, TPL-2) (MaxLight 40 | 5x 0.1 mL | Sign In for Pricing | |
| MBS6470346-01 | COT, CT (Cancer Osaka Thyroid Oncogene, c-COT, EST, ESTF, Mitogen-activated Protein Kinase Kinase Kinase 8, MAP3K8, MEKK8, Proto-oncogene c-Cot, Serine/threonine-protein Kinase Cot, Tumor Progression Locus 2, TPL2, TPL-2) (APC) | 0.2 mL | Sign In for Pricing | |
| MBS6470346-02 | COT, CT (Cancer Osaka Thyroid Oncogene, c-COT, EST, ESTF, Mitogen-activated Protein Kinase Kinase Kinase 8, MAP3K8, MEKK8, Proto-oncogene c-Cot, Serine/threonine-protein Kinase Cot, Tumor Progression Locus 2, TPL2, TPL-2) (APC) | 5x 0.2 mL | Sign In for Pricing | |
| MBS6470348-01 | COT, CT (Cancer Osaka Thyroid Oncogene, c-COT, EST, ESTF, Mitogen-activated Protein Kinase Kinase Kinase 8, MAP3K8, MEKK8, Proto-oncogene c-Cot, Serine/threonine-protein Kinase Cot, Tumor Progression Locus 2, TPL2, TPL-2) (FITC) | 0.2 mL | Sign In for Pricing | |
| MBS6470348-02 | COT, CT (Cancer Osaka Thyroid Oncogene, c-COT, EST, ESTF, Mitogen-activated Protein Kinase Kinase Kinase 8, MAP3K8, MEKK8, Proto-oncogene c-Cot, Serine/threonine-protein Kinase Cot, Tumor Progression Locus 2, TPL2, TPL-2) (FITC) | 5x 0.2 mL | Sign In for Pricing | |
| MBS6470350-01 | COT, CT (Cancer Osaka Thyroid Oncogene, c-COT, EST, ESTF, Mitogen-activated Protein Kinase Kinase Kinase 8, MAP3K8, MEKK8, Proto-oncogene c-Cot, Serine/threonine-protein Kinase Cot, Tumor Progression Locus 2, TPL2, TPL-2) (MaxLight 405) | 0.1 mL | Sign In for Pricing | |
| MBS6470350-02 | COT, CT (Cancer Osaka Thyroid Oncogene, c-COT, EST, ESTF, Mitogen-activated Protein Kinase Kinase Kinase 8, MAP3K8, MEKK8, Proto-oncogene c-Cot, Serine/threonine-protein Kinase Cot, Tumor Progression Locus 2, TPL2, TPL-2) (MaxLight 405) | 5x 0.1 mL | Sign In for Pricing | |
| MBS6470353-01 | COT, CT (Cancer Osaka Thyroid Oncogene, c-COT, EST, ESTF, Mitogen-activated Protein Kinase Kinase Kinase 8, MAP3K8, MEKK8, Proto-oncogene c-Cot, Serine/threonine-protein Kinase Cot, Tumor Progression Locus 2, TPL2, TPL-2) (MaxLight 650) | 0.1 mL | Sign In for Pricing | |
| MBS6470353-02 | COT, CT (Cancer Osaka Thyroid Oncogene, c-COT, EST, ESTF, Mitogen-activated Protein Kinase Kinase Kinase 8, MAP3K8, MEKK8, Proto-oncogene c-Cot, Serine/threonine-protein Kinase Cot, Tumor Progression Locus 2, TPL2, TPL-2) (MaxLight 650) | 5x 0.1 mL | Sign In for Pricing | |
| MBS6470356-01 | COT, CT (Cancer Osaka Thyroid Oncogene, c-COT, EST, ESTF, Mitogen-activated Protein Kinase Kinase Kinase 8, MAP3K8, MEKK8, Proto-oncogene c-Cot, Serine/threonine-protein Kinase Cot, Tumor Progression Locus 2, TPL2, TPL-2) (AP) | 0.2 mL | Sign In for Pricing | |
| MBS6470356-02 | COT, CT (Cancer Osaka Thyroid Oncogene, c-COT, EST, ESTF, Mitogen-activated Protein Kinase Kinase Kinase 8, MAP3K8, MEKK8, Proto-oncogene c-Cot, Serine/threonine-protein Kinase Cot, Tumor Progression Locus 2, TPL2, TPL-2) (AP) | 5x 0.2 mL | Sign In for Pricing | |
| AFG-ELL-2010 | Human Thyroid Cancer Cells (Undifferentiated) [KMH-2] | > 1x 10^6 Cells / Vial | Sign In for Pricing | |
| AFG-ELL-1215-01 | Culture Medium for Human Thyroid Cancer Cells (Undifferentiated) [8305C] | 125 mL | Sign In for Pricing | |
| AFG-ELL-1215-02 | Culture Medium for Human Thyroid Cancer Cells (Undifferentiated) [8305C] | 500 mL | Sign In for Pricing | |
| ETG244 | Thyroid cancer tissue array, including TNM and pathology grade, 6 cases/24 cores | 6 Cases / 24 Cores | Sign In for Pricing | |
| abx704034-01 | Complete Medium for Human Thyroid Cancer Tissue-Derived Cells | 100 mL | Sign In for Pricing | |
| abx704034-02 | Complete Medium for Human Thyroid Cancer Tissue-Derived Cells | 500 mL | Sign In for Pricing | |
| 123135-FITC | AKAP13 (A-kinase Anchor Protein 13, AKAP-13, AKAP-Lbc, Breast Cancer Nuclear Receptor-binding Auxiliary Protein, Guanine Nucleotide Exchange Factor Lbc, Human Thyroid-anchoring Protein 31, Lymphoid Blast Crisis Oncogene, LBC Oncogene, Non-oncogenic Rho GTPase-specific GTP Exchange Factor, Protein Kinase A-anchoring Protein 13, PRKA13, p47, BRX, HT31, LBC) (FITC) | 100 µL | Sign In for Pricing | |
| C7904-43F-APC | COT, phosphorylated (Thr290) (Cancer Osaka Thyroid Oncogene, c-COT, EST, ESTF, Mitogen-activated Protein Kinase Kinase Kinase 8, MAP3K8, MEKK8, Proto-oncogene c-Cot, Serine/threonine-protein Kinase Cot, Tumor Progression Locus 2, TPL2, TPL-2) (APC) discontinued | 200 µL | Sign In for Pricing | |
| C7904-43 | COT, Recombinant, Human, GST-Tag (Cancer Osaka Thyroid Oncogene, c-COT, EST, ESTF, Mitogen-activated Protein Kinase Kinase Kinase 8, MAP3K8, MEKK8, Proto-oncogene c-Cot, Serine/threonine-protein Kinase Cot, Tumor Progression Locus 2, TPL2, TPL-2) | 10 µg | Sign In for Pricing | |
| C7904-43G | COT, CT (Cancer Osaka Thyroid Oncogene, c-COT, EST, ESTF, Mitogen-activated Protein Kinase Kinase Kinase 8, MAP3K8, MEKK8, Proto-oncogene c-Cot, Serine/threonine-protein Kinase Cot, Tumor Progression Locus 2, TPL2, TPL-2) | 200 µL | Sign In for Pricing | |
| D9840-69 | DUSP26 (Dual Specificity Protein Phosphatase 26, DSP-4, Dual Specificity Phosphatase SKRP3, Low-molecular-mass Dual-specificity Phosphatase 4, LDP4, LDP-4, Mitogen-activated Protein Kinase Phosphatase 8, MAP Kinase Phosphatase 8, MKP8, MKP-8, Novel Amplified Gene in Thyroid Anaplastic Cancer, NATA1, SKRP3) discontinued | 50 µg | Sign In for Pricing | |
| D9840-69B | DUSP26 (Dual Specificity Protein Phosphatase 26, DSP-4, Dual Specificity Phosphatase SKRP3, Low-molecular-mass Dual-specificity Phosphatase 4, LDP4, LDP-4, Mitogen-activated Protein Kinase Phosphatase 8, MAP Kinase Phosphatase 8, MKP8, MKP-8, Novel Amplified Gene in Thyroid Anaplastic Cancer, NATA1, SKRP3) discontinued | 50 µg | Sign In for Pricing | |
| S6505-08G | SRC3, CT (NCOA3, Nuclear Receptor Coactivator 3, NCoA-3, ACTR, Amplified in Breast Cancer 1 Protein, AIB-1, CBP-interacting Protein, pCIP, Class E Basic Helix-loop-helix Protein 42, bHLHe42, Receptor-associated Coactivator 3, RAC-3, Steroid Receptor Coactivator Protein 3, SRC-3, Thyroid Hormone Receptor Activator Molecule 1, TRAM-1, AIB1, BHLHE42, RAC3, TRAM1) | 50 µg | Sign In for Pricing | |
| S6505-08B2 | SRC3 (NCOA3, Nuclear Receptor Coactivator 3, NCoA-3, ACTR, Amplified in Breast Cancer 1 Protein, AIB-1, CBP-interacting Protein, pCIP, Class E Basic Helix-loop-helix Protein 42, bHLHe42, Receptor-associated Coactivator 3, RAC-3, Steroid Receptor Coactivator Protein 3, SRC-3, Thyroid Hormone Receptor Activator Molecule 1, TRAM-1, AIB1, BHLHE42, RAC3, TRAM1) discontinued | 50 µg | Sign In for Pricing | |
| S6505-08B | SRC3 (Steroid receptor coactivator 3, NCOA3, Nuclear Receptor Coactivator 3, TRAM1, Thyroid Hormone Receptor Activator Molecule 1, RAC3, Receptor-Associated Coactivator 3, AIB1, Amplified in Breast Cancer-1, pCIP, CBP-Interacting protein) discontinued | 50 µg | Sign In for Pricing | |
| 406160-01 | C8orf4 (Protein C8orf4, Thyroid Cancer Protein 1, TC-1) | 50 µL | Sign In for Pricing | |
| 406160-02 | C8orf4 (Protein C8orf4, Thyroid Cancer Protein 1, TC-1) | 100 µL | Sign In for Pricing | |
| CM-H145-01 | Human Thyroid Cancer Tissue-Derived Cell Complete Medium | 100 mL | Sign In for Pricing | |
| CM-H145-02 | Human Thyroid Cancer Tissue-Derived Cell Complete Medium | 4x 125 mL | Sign In for Pricing | |
| TH8010a | Thyroid gland cancer tissue array with normal thyroid gland tissue, including TNM /Stage, 80 cases/80 cores, replacing TH8010-TH8010a | each | Sign In for Pricing | |
| NBP2-30317 | Human Thyroid Tissue MicroArray (Cancer) | 1 Slide | Sign In for Pricing | |
| MBS6145839-01 | AKAP13 (A-kinase Anchor Protein 13, AKAP-13, AKAP-Lbc, Breast Cancer Nuclear Receptor-binding Auxiliary Protein, Guanine Nucleotide Exchange Factor Lbc, Human Thyroid-anchoring Protein 31, Lymphoid Blast Crisis Oncogene, LBC Oncogene, Non-oncogenic Rho GT | 0.1 mL | Sign In for Pricing | |
| MBS6145839-02 | AKAP13 (A-kinase Anchor Protein 13, AKAP-13, AKAP-Lbc, Breast Cancer Nuclear Receptor-binding Auxiliary Protein, Guanine Nucleotide Exchange Factor Lbc, Human Thyroid-anchoring Protein 31, Lymphoid Blast Crisis Oncogene, LBC Oncogene, Non-oncogenic Rho GT | 5x 0.1 mL | Sign In for Pricing | |
| MBS6151142-01 | AKAP13 (A-kinase Anchor Protein 13, AKAP-13, AKAP-Lbc, Breast Cancer Nuclear Receptor-binding Auxiliary Protein, Guanine Nucleotide Exchange Factor Lbc, Human Thyroid-anchoring Protein 31, Lymphoid Blast Crisis Oncogene, LBC Oncogene, Non-oncogenic Rho GT | 0.1 mL | Sign In for Pricing | |
| MBS6151142-02 | AKAP13 (A-kinase Anchor Protein 13, AKAP-13, AKAP-Lbc, Breast Cancer Nuclear Receptor-binding Auxiliary Protein, Guanine Nucleotide Exchange Factor Lbc, Human Thyroid-anchoring Protein 31, Lymphoid Blast Crisis Oncogene, LBC Oncogene, Non-oncogenic Rho GT | 5x 0.1 mL | Sign In for Pricing | |